FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043285783> ?p ?o ?g. }

• W3043285783 endingPage "543" @default.
• W3043285783 startingPage "537" @default.
• W3043285783 abstract "BackgroundCoronavirus disease 2019 (COVID-19) remains a worldwide pandemic with a high mortality rate among patients requiring mechanical ventilation. The limited data that exist regarding the utility of extracorporeal membrane oxygenation (ECMO) in these critically ill patients show poor overall outcomes. This report describes our institutional practice regarding the application and management of ECMO support for patients with COVID-19 and reports promising early outcomes.MethodsAll critically ill patients with confirmed COVID-19 evaluated for ECMO support from March 10, 2020, to April 24, 2020, were retrospectively reviewed. Patients were evaluated for ECMO support based on a partial pressure of arterial oxygen/fraction of inspired oxygen ratio of less than 150 mm Hg or pH of less than 7.25 with a partial pressure of arterial carbon dioxide exceeding 60 mm Hg with no life-limiting comorbidities. Patients were cannulated at bedside and were managed with protective lung ventilation, early tracheostomy, bronchoscopies, and proning, as clinically indicated.ResultsAmong 321 patients intubated for COVID-19, 77 patients (24%) were evaluated for ECMO support, and 27 patients (8.4%) were placed on ECMO. All patients were supported with venovenous ECMO. Current survival is 96.3%, with only 1 death to date in more than 350 days of total ECMO support. Thirteen patients (48.1%) remain on ECMO support, and 13 patients (48.1%) have been successfully decannulated. Seven patients (25.9%) have been discharged from the hospital. Six patients (22.2%) remain in the hospital, of which 4 are on room air. No health care workers who participated in ECMO cannulation developed symptoms of or tested positive for COVID-19.ConclusionsThe early outcomes presented here suggest that the judicious use of ECMO support in severe COVID-19 may be clinically beneficial. Coronavirus disease 2019 (COVID-19) remains a worldwide pandemic with a high mortality rate among patients requiring mechanical ventilation. The limited data that exist regarding the utility of extracorporeal membrane oxygenation (ECMO) in these critically ill patients show poor overall outcomes. This report describes our institutional practice regarding the application and management of ECMO support for patients with COVID-19 and reports promising early outcomes. All critically ill patients with confirmed COVID-19 evaluated for ECMO support from March 10, 2020, to April 24, 2020, were retrospectively reviewed. Patients were evaluated for ECMO support based on a partial pressure of arterial oxygen/fraction of inspired oxygen ratio of less than 150 mm Hg or pH of less than 7.25 with a partial pressure of arterial carbon dioxide exceeding 60 mm Hg with no life-limiting comorbidities. Patients were cannulated at bedside and were managed with protective lung ventilation, early tracheostomy, bronchoscopies, and proning, as clinically indicated. Among 321 patients intubated for COVID-19, 77 patients (24%) were evaluated for ECMO support, and 27 patients (8.4%) were placed on ECMO. All patients were supported with venovenous ECMO. Current survival is 96.3%, with only 1 death to date in more than 350 days of total ECMO support. Thirteen patients (48.1%) remain on ECMO support, and 13 patients (48.1%) have been successfully decannulated. Seven patients (25.9%) have been discharged from the hospital. Six patients (22.2%) remain in the hospital, of which 4 are on room air. No health care workers who participated in ECMO cannulation developed symptoms of or tested positive for COVID-19. The early outcomes presented here suggest that the judicious use of ECMO support in severe COVID-19 may be clinically beneficial." @default.
• W3043285783 created "2020-07-23" @default.
• W3043285783 creator A5003035877 @default.
• W3043285783 creator A5011703939 @default.
• W3043285783 creator A5018679794 @default.
• W3043285783 creator A5031334485 @default.
• W3043285783 creator A5032906001 @default.
• W3043285783 creator A5060463866 @default.
• W3043285783 creator A5066001451 @default.
• W3043285783 creator A5066696989 @default.
• W3043285783 creator A5070890820 @default.
• W3043285783 creator A5074527297 @default.
• W3043285783 creator A5075572749 @default.
• W3043285783 date "2021-02-01" @default.
• W3043285783 modified "2023-09-30" @default.
• W3043285783 title "Extracorporeal Membrane Oxygenation Support in Severe COVID-19" @default.
• W3043285783 cites W1987783718 @default.
• W3043285783 cites W2165852759 @default.
• W3043285783 cites W2326579227 @default.
• W3043285783 cites W2803603947 @default.
• W3043285783 cites W2943765793 @default.
• W3043285783 cites W3008090866 @default.
• W3043285783 cites W3013643089 @default.
• W3043285783 cites W3014294089 @default.
• W3043285783 cites W3015675621 @default.
• W3043285783 cites W3016535995 @default.
• W3043285783 cites W3017304775 @default.
• W3043285783 cites W3018341597 @default.
• W3043285783 cites W3020673234 @default.
• W3043285783 doi "https://doi.org/10.1016/j.athoracsur.2020.07.002" @default.
• W3043285783 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7366119" @default.
• W3043285783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32687823" @default.
• W3043285783 hasPublicationYear "2021" @default.
• W3043285783 type Work @default.
• W3043285783 sameAs 3043285783 @default.
• W3043285783 citedByCount "68" @default.
• W3043285783 countsByYear W30432857832020 @default.
• W3043285783 countsByYear W30432857832021 @default.
• W3043285783 countsByYear W30432857832022 @default.
• W3043285783 countsByYear W30432857832023 @default.
• W3043285783 crossrefType "journal-article" @default.
• W3043285783 hasAuthorship W3043285783A5003035877 @default.
• W3043285783 hasAuthorship W3043285783A5011703939 @default.
• W3043285783 hasAuthorship W3043285783A5018679794 @default.
• W3043285783 hasAuthorship W3043285783A5031334485 @default.
• W3043285783 hasAuthorship W3043285783A5032906001 @default.
• W3043285783 hasAuthorship W3043285783A5060463866 @default.
• W3043285783 hasAuthorship W3043285783A5066001451 @default.
• W3043285783 hasAuthorship W3043285783A5066696989 @default.
• W3043285783 hasAuthorship W3043285783A5070890820 @default.
• W3043285783 hasAuthorship W3043285783A5074527297 @default.
• W3043285783 hasAuthorship W3043285783A5075572749 @default.
• W3043285783 hasBestOaLocation W30432857831 @default.
• W3043285783 hasConcept C126322002 @default.
• W3043285783 hasConcept C127413603 @default.
• W3043285783 hasConcept C177713679 @default.
• W3043285783 hasConcept C194828623 @default.
• W3043285783 hasConcept C200457457 @default.
• W3043285783 hasConcept C2776858399 @default.
• W3043285783 hasConcept C2777080012 @default.
• W3043285783 hasConcept C2779134260 @default.
• W3043285783 hasConcept C2780409771 @default.
• W3043285783 hasConcept C2780807750 @default.
• W3043285783 hasConcept C2991859549 @default.
• W3043285783 hasConcept C3008058167 @default.
• W3043285783 hasConcept C42219234 @default.
• W3043285783 hasConcept C524204448 @default.
• W3043285783 hasConcept C70289976 @default.
• W3043285783 hasConcept C71924100 @default.
• W3043285783 hasConcept C78519656 @default.
• W3043285783 hasConceptScore W3043285783C126322002 @default.
• W3043285783 hasConceptScore W3043285783C127413603 @default.
• W3043285783 hasConceptScore W3043285783C177713679 @default.
• W3043285783 hasConceptScore W3043285783C194828623 @default.
• W3043285783 hasConceptScore W3043285783C200457457 @default.
• W3043285783 hasConceptScore W3043285783C2776858399 @default.
• W3043285783 hasConceptScore W3043285783C2777080012 @default.
• W3043285783 hasConceptScore W3043285783C2779134260 @default.
• W3043285783 hasConceptScore W3043285783C2780409771 @default.
• W3043285783 hasConceptScore W3043285783C2780807750 @default.
• W3043285783 hasConceptScore W3043285783C2991859549 @default.
• W3043285783 hasConceptScore W3043285783C3008058167 @default.
• W3043285783 hasConceptScore W3043285783C42219234 @default.
• W3043285783 hasConceptScore W3043285783C524204448 @default.
• W3043285783 hasConceptScore W3043285783C70289976 @default.
• W3043285783 hasConceptScore W3043285783C71924100 @default.
• W3043285783 hasConceptScore W3043285783C78519656 @default.
• W3043285783 hasIssue "2" @default.
• W3043285783 hasLocation W30432857831 @default.
• W3043285783 hasLocation W30432857832 @default.
• W3043285783 hasLocation W30432857833 @default.
• W3043285783 hasLocation W30432857834 @default.
• W3043285783 hasOpenAccess W3043285783 @default.
• W3043285783 hasPrimaryLocation W30432857831 @default.
• W3043285783 hasRelatedWork W1481831050 @default.
• W3043285783 hasRelatedWork W1965514562 @default.
• W3043285783 hasRelatedWork W2051645286 @default.
• W3043285783 hasRelatedWork W2397236173 @default.

• next